Fundraising Fox

Chemastery

Entrepreneur First '20

London, GB · Founded 2020 · 15 known investors

chemastery.com

CheMastery builds a chemistry-agnostic software and hardware platform that automates and standardizes organic chemistry workflows, connecting R&D and manufacturing through robotic synthesis, purification, and reaction monitoring. It serves chemical research and manufacturing operations of all sizes across applications ranging from drug discovery to advanced materials.

Also known as cheMastery · CheMastery

Advanced ManufacturingDeep TechNew MaterialsRobotics

Founders & leadership

Chemastery was founded in 2020 by Stefan Glatzel and Anna Andreou.

SG
Stefan GlatzelinCo-founder and CTO
AAAnna Andreou
Anna AndreouinCo-founder & CEO

Investors · 15

Also in the syndicate · 6

BritbotsCur8DhyanFink Family OfficeKey Venturesundisclosed angel investors

Company profile

researched Aug 2026

CheMastery is a London, UK-based chemistry automation company that develops a chemistry-agnostic platform intended to standardise and automate organic chemistry workflows across both research and manufacturing. Its marketed offering is described as the "CheMastery Generation 4 Platform," positioned as a chemistry assistant capable of automating up to 90% of organic chemistry processes from R&D scale through to process scale, with stated aims of reproducibility, scale-up support and efficiency gains [0][3].

The company frames the problem it addresses in three parts: manual synthesis and purification methods that produce slow, costly and inconsistent results and impede standardisation and scalability; low chemical-sector productivity tied to supply chain reliability and logistics bottlenecks; and rising labour costs alongside difficulty retaining skilled chemists, which causes knowledge loss. It states that more than 65% of a chemist's daily work consists of manual, repetitive tasks and that practical chemistry has changed little in over 150 years [0]. Press coverage at the time of its seed round cited a higher figure, with the company estimating roughly 80% of an average chemist's lab time is spent on low-skill manual duties [4].

A third-party company database describes CheMastery as building chemistry automation infrastructure in London, developing pre-commercial demonstrators and co-locating chemists with engineering teams in purpose-built labs, listing the company as private with 1-10 employees and focus areas in chemical engineering, industrial automation and robotics. That source gives a founding year of 2019, which differs from other records [6].

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Disclosed funding roundsJan 2025$1
Employee countJan 20251-10
Investors on recordJan 202511 investors
Planned headcount growth following seed roundDec 2022300%
Share of a chemist's daily work consisting of manual, repetitive tasks (company Jan 202565%
Share of average chemist's lab time spent on low-skill manual duties (company esDec 202280%
Share of chemistry labs worldwide using process automation or productivity toolsJan 20255%
Share of organic chemistry workflows the platform can automate (R&D to process sJan 202590%

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 3

launches, deals, and filings
Dec 2022
Planned move to purpose-built premises with on-site manufacturing

CEO Anna Andreou stated the company would move into purpose-built premises enabling on-site manufacturing and immediate broadening of its product offering.

source ↗

Dec 2022
CheMastery closes oversubscribed multi-million-pound seed round

CheMastery announced an oversubscribed seed round described as "multi-million-pound"/"millions of pounds"; the exact amount was not disclosed. The round was led by Science Angel Syndicate and Undeterred Capital, with participation from Elbow Beach Capital, Britbots, HERmesa, Fink Family Office, Kadmos Capital, Formic Ventures, Cur8, Key Ventures, Dhyan and undisclosed angels. Proceeds were earmarked for headcount growth (the CEO cited a 300%/four-fold increase), a move into purpose-built premises enabling on-site manufacturing, and broadening the product offering.

source ↗

Dec 2022
Working prototype of chemistry automation system delivered

At the time of the seed announcement, CheMastery had delivered a working prototype (MVP) of its automation tools and planned a next iteration ahead of paid pilot trials.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Chemastery do?
London-based CheMastery builds a chemistry-agnostic automation platform for organic synthesis in research and manufacturing.
Who founded Chemastery?
Chemastery was founded by Stefan Glatzel, Anna Andreou in 2020.
Who are Chemastery's investors?
Chemastery's investors include 7percent Ventures, Blackfinch Ventures, Elbow Beach Capital, Entrepreneur First, Undeterred Capital, Formic Ventures, HERmesa, Kadmos Capital and 1 more.
Where is Chemastery headquartered?
Chemastery is headquartered in London, GB.